Home
About
Overview
Sharing Data
ORCID
Help
History (93)
Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques.
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis.
Risk factors for prenatal depressive symptoms among Hispanic women.
The controversy inherent in managing frail nursing home residents during complex hurricane emergencies.
Heterologous prime-boost vaccination.
See All 93 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Heterologous prime-boost vaccination.
Lu S. Heterologous prime-boost vaccination. Curr Opin Immunol. 2009 Jun; 21(3):346-51.
View in:
PubMed
subject areas
AIDS Vaccines
Animals
Cancer Vaccines
HIV Infections
Humans
Immunization, Secondary
Neoplasms
Research
Research Design
Vaccination
authors with profiles
Shan Lu MD, PhD